<code id='3486E78ABE'></code><style id='3486E78ABE'></style>
    • <acronym id='3486E78ABE'></acronym>
      <center id='3486E78ABE'><center id='3486E78ABE'><tfoot id='3486E78ABE'></tfoot></center><abbr id='3486E78ABE'><dir id='3486E78ABE'><tfoot id='3486E78ABE'></tfoot><noframes id='3486E78ABE'>

    • <optgroup id='3486E78ABE'><strike id='3486E78ABE'><sup id='3486E78ABE'></sup></strike><code id='3486E78ABE'></code></optgroup>
        1. <b id='3486E78ABE'><label id='3486E78ABE'><select id='3486E78ABE'><dt id='3486E78ABE'><span id='3486E78ABE'></span></dt></select></label></b><u id='3486E78ABE'></u>
          <i id='3486E78ABE'><strike id='3486E78ABE'><tt id='3486E78ABE'><pre id='3486E78ABE'></pre></tt></strike></i>

          knowledge

          knowledge

          author:explore    Page View:72785
          John-Arne-Røttingen, a white man with short hair, smiles at the camera wearing blue suits — biotech coverage from STAT
          John-Arne Røttingen is the head of the Wellcome Trust, one of the world’s top private funders of biomedical research. Illustration: STAT; Source: Wellcome Trust

          LONDON — The key groups involved in addressing global health problems often include governments, foundations, and pharmaceutical companies.

          But to John-Arne Røttingen, the new head of the Wellcome Trust, one of the world’s top private funders of biomedical research, there’s another sector that should be getting involved — the tech industry.

          advertisement

          The Alphabets and Amazons of the world have been growing their health-related initiatives, but the industry is rarely mentioned when neglected public health issues are discussed, Røttingen argued.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Wildfire smoke exposes gaps in outdoor worker protections
          Wildfire smoke exposes gaps in outdoor worker protections

          ApersonwaitingforthesubwaywearsafilteredmaskassmokyhazefromwildfiresinCanadablanketsaneighborhoodinN

          read more
          Readout LOUD Podcast: Legal insider trading, booming biotech stocks
          Readout LOUD Podcast: Legal insider trading, booming biotech stocks

          Arebiotech’sdogdaysover?What’saPIPE?AndwhatcanunseatWegovy?Wecoverallthatandmorethisweekon“TheReadou

          read more
          Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
          Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

          6:16PresidentJoeBidenspeaksintheRooseveltRoomoftheWhiteHouse,June30,2023.EvanVucci/APPresidentJoeBid

          read more

          Readout Newsletter: Ironwood, Pfizer, FogPharma updates

          DavidLRyan/TheBostonGlobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourb